GE Healthcare and biotech firm Geron agreed to develop and market cellular assay products based on human embryonic stem cell lines for use in drug discovery, development and toxicity screening. The stem cell lines are licensed by Geron from the Wisconsin Alumni Research Foundation and are listed on the National Institutes of Health Human Pluripotent Stem Cell Registry.

Related Summaries